Jan 5 (Reuters) - Metagenomi Technologies, a genetic medicines company backed by Bayer Healthcare and Moderna , filed for an initial public offering in the United States on Friday. (Reporting by Niket Nishant in Bengaluru; Editing by Pooja Desai)
Market Closed -
Other stock markets
|
After market 07:00:00 pm | |||
148.6 USD | -1.60% | 148.5 | -0.06% |
Jun. 10 | Health Care Up on Defensive Bias -- Health Care Roundup | DJ |
Jun. 10 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
148.6 USD | -1.60% | +0.52% | 56.95B | ||
27.54 EUR | +0.25% | -4.02% | 29B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.41% | 56.95B | |
+41.65% | 40.26B | |
-6.72% | 39.32B | |
-5.96% | 28.37B | |
+12.99% | 26.45B | |
-19.82% | 19.41B | |
+32.35% | 12.54B | |
-0.08% | 12.15B | |
+25.18% | 12.21B | |
-9.26% | 11.05B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna-backed genetic drugs firm Metagenomi files for US IPO